90 related articles for article (PubMed ID: 24098023)
1. External quality assessment of BRAF molecular analysis in melanoma.
Deans ZC; Wallace A; O'Sullivan B; Purvis A; Camus S; Fairley JA; Gonzalez D
J Clin Pathol; 2014 Feb; 67(2):120-4. PubMed ID: 24098023
[TBL] [Abstract][Full Text] [Related]
2. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.
Deans ZC; Bilbe N; O'Sullivan B; Lazarou LP; de Castro DG; Parry S; Dodson A; Taniere P; Clark C; Butler R
J Clin Pathol; 2013 Apr; 66(4):319-25. PubMed ID: 23378269
[TBL] [Abstract][Full Text] [Related]
3. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
4. External quality assessment: best practice.
James D; Ames D; Lopez B; Still R; Simpson W; Twomey P
J Clin Pathol; 2014 Aug; 67(8):651-5. PubMed ID: 24621574
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
[TBL] [Abstract][Full Text] [Related]
6. RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009-2016).
Richman SD; Fairley J; Butler R; Deans ZC
Virchows Arch; 2017 Dec; 471(6):721-729. PubMed ID: 28653203
[TBL] [Abstract][Full Text] [Related]
7. [BRAF mutation testing for the choice of melanoma treatment].
Imianitov EN
Arkh Patol; 2012; 74(5):65-71. PubMed ID: 23342664
[TBL] [Abstract][Full Text] [Related]
8. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
[TBL] [Abstract][Full Text] [Related]
9. Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting.
Treece AL; Gulley ML; Vasalos P; Paquette C; Lindeman NI; Jennings LJ; Bartley AN
Arch Pathol Lab Med; 2017 May; 141(5):658-665. PubMed ID: 28447902
[TBL] [Abstract][Full Text] [Related]
10. Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility.
Marin C; Beauchet A; Capper D; Zimmermann U; Julié C; Ilie M; Saiag P; von Deimling A; Hofman P; Emile JF
Arch Pathol Lab Med; 2014 Jan; 138(1):71-5. PubMed ID: 23651150
[TBL] [Abstract][Full Text] [Related]
11. Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples.
Didelot A; Le Corre D; Luscan A; Cazes A; Pallier K; Emile JF; Laurent-Puig P; Blons H
Exp Mol Pathol; 2012 Jun; 92(3):275-80. PubMed ID: 22426079
[TBL] [Abstract][Full Text] [Related]
12. Molecular testing in malignant melanoma.
Grossmann AH; Grossmann KF; Wallander ML
Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
[TBL] [Abstract][Full Text] [Related]
13. Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.
Dequeker EM; Keppens C; Egele C; Delen S; Lamy A; Lemoine A; Sabourin JC; Andrieu C; Ligtenberg M; Fetique D; Tops B; Descarpentries C; Blons H; Denoux Y; Aube C; Penault-Llorca F; Hofman P; Leroy K; Le Marechal C; Doucet L; Duranton-Tanneur V; Pedeutour F; Soubeyran I; Côté JF; Emile JF; Vignaud JM; Monhoven N; Haddad V; Laurent-Puig P; van Krieken H; Nowak F; Lonchamp E; Bellocq JP; Rouleau E
J Mol Diagn; 2016 Mar; 18(2):205-14. PubMed ID: 26752307
[TBL] [Abstract][Full Text] [Related]
14. Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region.
Amanuel B; Grieu F; Kular J; Millward M; Iacopetta B
Pathology; 2012 Jun; 44(4):357-9. PubMed ID: 22614711
[TBL] [Abstract][Full Text] [Related]
15. Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias.
Seneca S; Morris MA; Patton S; Elles R; Sequeiros J
Eur J Hum Genet; 2008 Aug; 16(8):913-20. PubMed ID: 18301445
[TBL] [Abstract][Full Text] [Related]
16. Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group.
Emile JF; Tisserand J; Bergougnoux L; Nowak F; Faucher G; Surel S; Lamy A; Lecorre D; Helias-Rodzewicz Z; Hofman P; Sabourin JC; Laurent-Puig P;
BMC Cancer; 2013 Oct; 13():472. PubMed ID: 24119386
[TBL] [Abstract][Full Text] [Related]
17. [Significance of participation in programs of external quality assessment in molecular diagnostic--our experience].
Paro MM; Siftar Z; Juretić D; Flegar-Mestrić Z
Acta Med Croatica; 2011 Sep; 65 Suppl 1():105-14. PubMed ID: 23126037
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
Long GV; Menzies AM; Nagrial AM; Haydu LE; Hamilton AL; Mann GJ; Hughes TM; Thompson JF; Scolyer RA; Kefford RF
J Clin Oncol; 2011 Apr; 29(10):1239-46. PubMed ID: 21343559
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
[TBL] [Abstract][Full Text] [Related]
20. First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing.
Meini G; Dello Russo C; Allice T; Barresi R; D'Arrigo R; Falasca F; Lipsi MR; Paolucci S; Zanussi S; Antonetti R; Baldanti F; Basaglia G; Bruzzone B; Polilli E; Ghisetti V; Pucillo LP; Turriziani O; Pirazzoli A; Navarra P; Zazzi M
J Clin Virol; 2016 May; 78():1-3. PubMed ID: 26946153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
